SAMHSA holding opioid recovery app challenge

Beth Walsh | | Health Exec | Precision Medicine

The Substance Abuse and Mental Health Services Administration (SAMHSA) is holding a challenge for an innovative mobile app to provide opioid recovery support for patients receiving medication-assisted treatment for opioid use disorders.

The organization is seeking a free, user-friendly opioid recovery support app available to patients in recovery who are receiving outpatient medication-assisted treatment. Any features, tools or assets in the app need to be tied to the evidence-based insights provided.

Those undergoing medication-assisted treatment (MAT) could benefit from a mobile app for smartphones that provides features and information that supports their maintenance in recovery, according to SAMHSA.

$32,500 in prizes are up for grabs and those interested can submit until May 28. Learn more.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.